The CDS features an integrated view of the assembled human genome sequence and its catalog of human genes and proteins generated through proprietary computational methods with further refinement and on-going analysis by Celera’s scientists.
The CDS Biomolecule report is the main viewing application for CDS that gives researchers the capability to integrate information about each gene and protein structure, function and role in normal physiological and disease processes. The Celera mouse genome sequence is another important CDS feature used for the accurate annotation of human genes in Celera’s high quality computational and hand curated gene predictions.
The new version of the Celera Discovery System offers a flexible discovery platform that should enable life sciences researchers to identify genes important to their specific research programs, and to understand their function and role in human disease. This is accomplished by combining comprehensive data with the review and annotation of human genes and proteins by Celera scientists and bioinformatics experts, said Dr J. Craig Venter, Celera’s president and CSO in a commentary to the press.
CDS provides our subscribers with a novel approach to exploring genome scale data now, and it lays the foundation to expand and integrate gene expression and proteomics data, protein structure, genetic variation, scientific literature and other data and information sources as the product evolves to meet our customers’ needs.
